Wire · opportunities
Coreline Soft Secures 13th FDA Clearance with AI-Powered Aortic Measurement Software
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 19 October 2026 · Fusion42 review
South Korean medical AI company Coreline Soft has received its 13th U.S. FDA 510(k) clearance for AVIEW Aorta Metrics, expanding its chest CT-based AI portfolio into cardiovascular imaging with automated aortic segmentation and diameter measurement. This clearance supports the company’s growing U.S. commercial presence through integration with hospital imaging workflows and aligns with emerging trends in quantitative imaging analysis and reimbursement.
This Wire brief sits within Fusion42's coverage of Healthtech Infrastructure, and 2 sources have reported it between 19 Oct 2026 and 23 Oct 2026.
◆ ◆ The Wire takeaway
Coreline Soft’s new FDA clearance opens a clear route for you to extend AI imaging from lung disease to cardiovascular analysis using existing chest CT scans. This creates an opportunity to integrate multi-use AI tools into hospital workflows and push for wider adoption in U.S. clinical settings.
◆ Coverage
2 sources · first reported 19 Oct 2026 · latest 23 Oct 2026
◆ Related on Wire
◆ Topics